Divis Laboratories Ltd.

Divis Laboratories is currently trading at Rs. 1130.00, down by 33.60 points or 2.89% from its previous closing of Rs. 1163.60 on the BSE.

The scrip opened at Rs. 1129.00 and has touched a high and low of Rs. 1132.50 and Rs. 1090.55 respectively. So far 33,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1380.00 on 16-Sep-2016 and a 52 week low of Rs. 918.10 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs. 1169.00 and Rs. 1090.55 respectively. The current market cap of the company is Rs. 30,118.74 crore.

The promoters holding in the company stood at 52.06%, while Institutions and Non-Institutions held 34.45% and 13.49% respectively.

Divis Laboratories’ Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US Food and Drug Administration (USFDA) from November 29, 2016 to December 06, 2016. The company has been issued a form 483 with 5 observations and these shall be responded within the time permitted.

Earlier, the company had successful inspection by the USFDA for its Unit-2 at Chippada, Bheemunipatnam near Visakhapatnam during February, 2016 with no observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.